Should antiviral treatment be initiated when hepatitis B transaminase levels are over 80?
Mar 28, 2023
Source: Cainiu Health
Dr. Jiang Weimin
Introduction
ALT level of over 80 U/L in hepatitis B usually requires antiviral treatment. Hepatitis B is a chronic liver disease primarily caused by persistent HBV infection, where HBV (hepatitis B virus) damages the liver and impairs liver function. An ALT level above 80 U/L indicates existing liver damage; without antiviral therapy, liver damage may progressively worsen.
Elevated hepatitis B transaminase levels, specifically over 80 U/L, generally require antiviral treatment.
Hepatitis B is a chronic liver disease caused by persistent infection with the hepatitis B virus (HBV). HBV damages the liver and impairs liver function. A transaminase level exceeding 80 U/L indicates existing liver damage. Without antiviral therapy, liver injury may worsen and could lead to liver failure in severe cases. Treatment typically involves antiviral medications such as entecavir dispersible tablets, lamivudine tablets, or tenofovir tablets, which help suppress the hepatitis B virus, under a doctor's guidance.
Hepatitis B is infectious and can be transmitted through blood, mother-to-child transmission, and sexual contact. It is important to follow medical advice regarding medication and undergo regular follow-up examinations to monitor disease progression.
